Zaleplon and Tinnitus - a phase IV clinical study of FDA data

Summary:

Tinnitus is reported only by a few people who take Zaleplon.

The phase IV clinical study analyzes which people take Zaleplon and have Tinnitus. It is created by eHealthMe based on reports of 1,610 people who have side effects while taking Zaleplon from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 02, 2023

1,610 people reported to have side effects when taking Zaleplon.
Among them, 4 people (0.25%) have Tinnitus.

What is Zaleplon?

Zaleplon has active ingredients of zaleplon. It is often used in insomnia. eHealthMe is studying from 1,690 Zaleplon users for its effectiveness, alternative drugs and more.

What is Tinnitus?

Tinnitus (a ringing in the ears) is found to be associated with 3,241 drugs and 2,780 conditions by eHealthMe.

Number of Zaleplon and Tinnitus reports submitted per year:

Time on Zaleplon when people have Tinnitus *:

Gender of people who have Tinnitus when taking Zaleplon *:

female: 25 %
male: 75 %

Age of people who have Tinnitus when taking Zaleplon *:

Common drugs people take besides Zaleplon *:

Common side effects people have besides Tinnitus *:

Urinary Tract Infection: 1 person, 25.00%
Urinary Retention (the inability to completely or partially empty the bladder): 1 person, 25.00%
Bipolar Disorder (mood disorder): 1 person, 25.00%
Drowsiness: 1 person, 25.00%
Drug Ineffective: 1 person, 25.00%
Ejaculation Delayed: 1 person, 25.00%
Gait Disturbance: 1 person, 25.00%
Hearing Loss: 1 person, 25.00%
Joint Pain: 1 person, 25.00%
Nausea (feeling of having an urge to vomit): 1 person, 25.00%

Common conditions people have *:

Urination - Excessive Volume: 1 person, 25.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 25.00%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 25.00%
Migraine (headache): 1 person, 25.00%
Fatigue (feeling of tiredness): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Zaleplon and have Tinnitus?

Check whether Tinnitus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Tinnitus and when was it recovered:

Tinnitus in Zaleplon

Expand to all the drugs that have ingredients of zaleplon:

Tinnitus and drugs with ingredients of zaleplon (55 reports)

Alternative drugs to, pros and cons of Zaleplon:

Zaleplon (1,690 reports)

Common Zaleplon side effects:

Drug ineffective: 162 reports
Stress and anxiety: 123 reports

Browse all side effects of Zaleplon:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Tinnitus treatments and more:

Tinnitus (51,713 reports)

COVID vaccines that are related to Tinnitus:

Common drugs associated with Tinnitus:

All the drugs that are associated with Tinnitus:

Tinnitus (3,241 drugs)

Common conditions associated with Tinnitus:

All the conditions that are associated with Tinnitus:

Tinnitus (2,780 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on zaleplon (the active ingredients of Zaleplon) and Zaleplon (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.